课题基金 / 基金详情

Using Markov Decision Processes to Optimize Breast Biopsy Decision Making

Using Markov Decision Processes to Optimize Breast Biopsy Decision Making
使用马尔可夫决策过程来优化乳腺活检决策
批准号:
7559005
负责人:
Oguzhan Alagoz
金额:
$15.33万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-01 至 2011-01-31

项目摘要

项目成果

Oguzhan Alagoz的其他基金

相似基金

相关文献

中文摘要
翻译
项目简介:通过筛查乳房X光检查进行早期诊断是降低乳腺癌死亡率的最有效手段。虽然乳房X光检查费用不高,但由检测到的异常(假阳性和真阳性)导致的介入性手术显著增加了这一基于人群的筛查计划的成本。事实上,乳腺活检实际上在超过80%的病例中提供了良性结果,使其成为乳腺癌筛查计划中人均成本最高的部分。如果乳房X光检查报告有可疑发现,则需要进行活检以确定异常是否真的是乳腺癌。假阳性乳房X光检查使患者面临焦虑、疼痛和可能的并发症,而医疗保健系统则承担可能不必要的活检费用。我们之前的研究开发了一个称为乳房摄影贝叶斯网络(MBN)的概率计算机模型,该模型根据人口统计学风险因素和乳房X光检查结果计算乳房疾病的风险。这项研究的目的是优化乳腺癌患者的活检决策,以提高浸润性乳腺癌的早期诊断,同时最大限度地减少不必要的侵入性操作。我们将校准我们之前开发的MBN,以根据人口统计学风险因素和乳房X光检查结果准确计算乳腺癌的风险。我们将使用马尔可夫决策过程,这是一种先进的决策分析技术,用于在不确定的情况下进行决策,以找到不同年龄组患者进行乳房活检的最佳概率阈值。我们将确定这些最佳概率阈值是否会随着患者年龄的变化而变化。这项研究与公共卫生的相关性:这项拟议的研究将改进筛查乳房X光检查的解释,这是降低乳腺癌死亡率的最有效手段,乳腺癌在美国影响着数百万女性。筛查乳房X光检查的任何改进都将降低社会不必要的活检成本。
英文摘要
DESCRIPTION (provided by applicant): Project Summary Early diagnosis through screening mammography is the most effective means of decreasing the death rate from breast cancer. While mammography is inexpensive, the interventional procedures that result from detected abnormalities (both false and true positives) increase the cost of this population-based screening program significantly. In fact, breast biopsy actually delivers a benign result in over 80% of cases making it the most costly per capita component of a breast cancer screening program. If a mammogram reports a suspicious finding, then a biopsy is required to decide whether an abnormality is in fact a breast cancer. A false positive mammogram exposes the patient to the anxiety, pain, and possible complications while the health care system bears the cost of potentially unnecessary biopsies. Our previous research has developed a probabilistic computer model called the Mammography Bayesian Network (MBN) that calculates the risk of breast disease based on demographic risk factors and mammography findings. The objective of this research is to optimize the biopsy decisions for breast-cancer patients such that the early diagnosis of invasive breast cancer is improved while unnecessary invasive procedures are minimized. We will calibrate our previously developed MBN, to accurately calculate the risk of breast cancer based on demographic risk factors and mammography findings. We will use Markov decision processes, an advanced decision analysis technique that is used for decision- making under uncertainty, to find the optimal probability thresholds for the decision to perform breast biopsy for patients with different age groups. We will determine whether these optimal probability thresholds change with patient age. Relevance of this research to Public Health: The proposed research will improve the interpretation of screening mammography, the most effective means of decreasing the death rate from breast cancer, which affects millions of women in the US. Any improvement in screening mammography will reduce the costs of unnecessary biopsies to the society.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Estimating and Mitigating Thyroid Cancer Overdiagnosis: A Mathematical Modeling Approach
  • 批准号:
    10623193
  • 项目类别:
  • 资助金额:
    $42.23万
  • 财政年份:
    2020
  • 负责人:
    Oguzhan Alagoz
  • 依托单位:
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum
  • 批准号:
    10251326
  • 项目类别:
  • 资助金额:
    $196.76万
  • 财政年份:
    2020
  • 负责人:
    Oguzhan Alagoz
  • 依托单位:
Estimating and Mitigating Thyroid Cancer Overdiagnosis: A Mathematical Modeling Approach
  • 批准号:
    10239049
  • 项目类别:
  • 资助金额:
    $51.8万
  • 财政年份:
    2020
  • 负责人:
    Oguzhan Alagoz
  • 依托单位:
Estimating and Mitigating Thyroid Cancer Overdiagnosis: A Mathematical Modeling Approach
  • 批准号:
    10307232
  • 项目类别:
  • 资助金额:
    $10.05万
  • 财政年份:
    2020
  • 负责人:
    Oguzhan Alagoz
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: